Caption Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Caption Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-19,900	Closed	-$689K	–	1765
2025 Q3	$689K	Sell	19,900 -265,400	-93%	-$8.49M	0.01%	1222
2025 Q2	$7.99M	Buy	285,300 +186,200	+188%	+$4.99M	0.09%	269
2025 Q1	$2.49M	Sell	99,100 -900	-0.9%	-$22.7K	0.02%	615
2024 Q4	$2.75M	Buy	+100,000	New	+$2.79M	0.03%	584
2023 Q4	–	Sell	-45,000	Closed	-$1.55M	–	1461
2023 Q3	$1.55M	Buy	45,000 +15,000	+50%	+$584K	0.02%	645
2023 Q2	$1.22M	Sell	30,000 -63,800	-68%	-$2.6M	0.02%	620
2023 Q1	$3.62M	Hold	93,800	–	–	0.07%	305
2022 Q4	$4.16M	Buy	+93,800	New	+$3.95M	0.06%	346
2022 Q2	–	Sell	-105,000	Closed	-$6.51M	–	1584
2022 Q1	$6.51M	Sell	105,000 -30,000	-22%	-$1.84M	0.08%	345
2021 Q4	$7.44M	Buy	135,000 +60,000	+80%	+$3.13M	0.08%	331
2021 Q3	$3.95M	Buy	+75,000	New	+$4.45M	0.05%	538
2020 Q1	–	Sell	-20,000	Closed	-$4.14M	–	936
2019 Q4	$4.14M	Buy	+20,000	New	+$3.7M	0.14%	204

Other funds holding LKFT

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Caption Management's LKFT Position: Q2 2023 in Review

Caption Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2023, closing a stake of 19,826 shares — an estimated $809K sold.

Caption Management first reported a position in LKFT in Q4 2020 and held it in 8 quarters. The position peaked at $5.52M in Q1 2021. 76 funds tracked by Wall St. Rank hold LKFT as of Q2 2023.

Caption Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2023 after selling out during the quarter.
Caption Management sold 19,826 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2023, an estimated $809K.
Caption Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2020 and held it in 8 quarters.
Caption Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $5.52M in Q1 2021.
76 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2023.

Based on Caption Management's 13F filing for Q2 2023, filed 14 Aug 2023.